Florida Drugmaker Draws FDA Warning for Repackaging, Distribution

Drug Industry Daily
A A
The FDA warned Phase 4 Pharmaceutical for repackaging deficiencies and inadequate drug distribution procedures at its Aventura, Florida facility.

To View This Article:

Login

Subscribe To Drug Industry Daily